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Pseudomonas aeruginosa of human origin has been 
found to be antagonistic to Candida albicans from the same 
habitat. In-vitro studies showed the presence of an anti¬ 
biotic substance produced by Pseudomonas. Clinical isolates 
of these organisms were tested in associative cultures and 
while the Candida isolates were uniformly inhibited, 
Pseudomonas spp. displayed variability in their inhibitory 
capacity. Sterile filtrates on spent Pseudomonas broth 
cultures, when spotted on the surface of Candida seeded 
overlays, induced discrete zones of inhibition. Two compounds 
were responsible* pyocyanine, which exhibits a wide zone 
of incomplete inhibition, and phenazine-l-carboxylic acid, 
which exhibits a narrow zone of complete inhibition. It 
appears that each compound reinforces the other and together 
these are responsible for the inhibitory effect observed 
with the crude filtrate. 
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INTRODUCTION 
The advances made in medicine during the past decade 
have been accompanied by an increasing incidence of 
opportunistic infections. Patients acquiring infections 
are considered immunologically incompetent and are unable 
to defend themselves against the most innocuous organisms. 
The indigenous microflora of the healthy individual becomes 
life-threatening to those who undergo extensive diagnostic 
and therapeutic regimens and prolonged hospitalization. 
Recovery from the underlying disease is aggravated by the 
complication of infection for which medication is often 
ineffective. Antibiotic resistance among opportunistic 
organisms is widely recognized and while a few specific 
anti-microbial agents are available, their toxicity restricts 
general usage. 
Two particularly evident opportunists are Candida 
albicans, a yeast, and Pseudomonas aeruginosa, a bacterium. 
Presently, there is an increasing incidence of infections 
due to these organisms among the severely debilitated 
receiving broad spectrum antibiotic therapy. Eradication 
of the normal flora colonizing the respiratory and intestinal 
tracts provides an ideal non-competitive habitat for these 
opportunists to proliferate. 
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The yeast ordinarily occurs in small numbers in the 
upper respiratory tract, an environment heavily laden with 
a competitive flora. When this habitat is altered, C. 
albicans multiplies and may progress to the lungs. Such 
systemic infections are difficult to control. Of the two 
Candida specific drugs available, nystatin and amophotericin 
B, only the latter is effective for systemic infection. 
This agent, however, is exceedingly toxic and is not 
generally administered. 
The bacterium, Pseudomonas, is somewhat similar; it 
is commonly found in moist areas of the inanimate environ¬ 
ment. From these sources colonization of the human 
respiratory and intestinal tract readily occurs. Its 
significance when found within the healthy host is problem¬ 
atic, although traditionally, it has been considered part 
of the normal flora. These and other opportunists present 
a diagnostic and therapeutic dilemma to the physician. 
Diagnosis must consider not only the organism, their numbers 
and relative proportion, but more importantly the ability 
of the patient to resist their progress. 
Since both Candida albicans and Pseudomonas 
aeruginosa are (a) ubiquitous, (b) opportunists, (c) re¬ 
sistant to antibiotics and (d) have the same temperature 
preference, they should, in theory, be regularly isolated 
from the immunologically susceptible patient. We have 
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observed that this is not the case. Either one or the 
other, but rarely both, are isolated from the same indi¬ 
vidual. This observation led to studies of their associative 
behavior, which discloses that Pseudomonas is antagonistic 
towards Candida, and attempts to determine the agents 
responsible for this antagonism. 
4 
LITERATURE REVIEW 
It is exceedingly unlikely that two populations 
growing in the same habitat do not interact. The prudent 
observation made by Lucas (23) in 1949 that, "Mere toleration 
is biologically and statistically improbable," is becoming 
increasingly evident. Neutralism is the term used to 
describe associations in which different biological species 
coexist, each indifferent to the others presence. Such 
association probably occurs only when the populations are 
physically far apart or the physiological requirements are 
so different that neither organism exerts an influence on 
the other. As a result, neutralistic associations have 
received little interest and have not been systematically 
studied (4). 
The study of microbial associations has revealed a 
variety of possible interactions. Unfortunately, there is 
a tendency to consider these interactions of neutralism, 
commensalism, antagonism and synergism as independent and 
unchanging. This is a major fault, especially in the 
assessment of the human microflora, in that rigid criteria 
dealing only with benefit or harm are oversimplifications 
of complex interactions. This may be illustrated by the 
commensals which colonize the respiratory tract, especially 
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the streptococci and yeasts. While these two organisms 
are everpresent they very rarely cause disease. When disease 
does occur it's primarily due to changes on the part of the 
host and not to the inherent virulence of the organism. In 
light of this, it is becoming clear that the terms "pathogen" 
and "non-pathogen" may also be an oversimplification and 
should be replaced with terms which consider both the host 
and the organism (9)* Present understanding of microbial 
interactions within the human body is limited, since it is 
an ecological problem that must consider not only the 
indigenous flora but exogenously acquired organisms as well. 
Unfortunately, most of the present knowledge regarding 
microbial interactions is the result of in-vitro and bovine 
rumen investigations and is extremely limited. 
A particularly attractive concept of interaction 
has been that of antagonism; associations characterized 
by suppression of one organism for the benefit of the other. 
In the past decade there has been renewed interest in the 
prospect of promoting microbial antagonism not only as a 
means of suppressing infectious diseases of man, but also 
bacterial control of insects, vermin and rodents. Due to 
the indiscriminate use of pesticides and the problems 
attributed to these chemicals, biological control systems 
are rapidly gaining favor and much effort is being expended 
at the present time developing appropriate and efficient 
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biological control systems. 
A considerable amount of work has been reported 
utilizing both in-vivo and in-vitro conditions in the control 
of infectious diseases by competitive inhibition. The in- 
vivo studies have demonstrated unequivocally that bacterial 
interference can be used to augment man's ability to resist 
disease. 
The terminology used in these studies generally 
includes the following* (1) Test strain—the organism being 
antagonized, suppressed or killed; (2) Effector strain— 
the organism responsible for the antagonism and (3) 
Bacterial interference—the phenomenon of antagonism by 
one organism toward another and synonymous with competitive 
interaction. 
The concept of infectious disease control by promoting 
competitive interaction was first introduced in 1885 by 
Contani (8) who attempted treatment of tuberculosis by 
replacement of the tubercle bacillus with a mixture of 
indigenous species. In 1906 Emmerich (8) injected beta- 
hemolytic streptococci with the prospect of preventing the 
spread of anthrax. Florey's review (8) of the use of micro¬ 
organisms for therapeutic purposes examines the research of 
Metchnikoff and others at the beginning of this century and 
discusses the possible reasons for the failure of the concept. 
On the other hand, success of this concept is most dramati¬ 
cally illustrated by the experience of Wagner and Jauregg 
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who employed malarial fever therapy for the treatment of 
syphillis (6t 32t ^3). 
This early era of natural therapy ended in the 1930's 
with the development of sulfa drugs and penicillin. At this 
time, interest in microbial antagonism as a means of therapy 
was pre-empted by the antibiotic era that followed. The 
concept received little attention until the 196o's when two 
discouraging shifts were observed by the clinical micro¬ 
biologists (1) antibiotic resistant strains of bacteria 
were becoming more prevalent and (2) gram negative bacilli, 
formerly considered innocuous, were more frequently documented 
as etiologic agents of infectious disease. These two trends 
indicated the limitations of chemotherapy and a renewed 
interest in biological control followed. 
Shinefield et al (3^» 35) in 1963» were among the 
first to reinvestigate biological control when they implanted 
avirulent Staphylococcus aureus strain 5°2A on the nasal 
mucosa and the umbilicus of newborn infants and successfully 
interrupted transmission of epidemic strains among the 
nursery population. The same avirulent strain was also 
successfully established in the nasal mucosa of adults who 
had previously carried virulent strains of S. aureus. 
Staphylocci have also been shown to inhibit a wide variety 
of other gram positive bacteria including Corynebacterium 
diptheriae and Nocardia species, y.ycobacterium smegmatis, 
Bacillus, Clostridium and other Staphylococcus species 
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have been evaluated in competition with S. aureus and were 
found susceptible in-vitro (11). 
Monosporium apiospermum.a fungus, has been reported 
by Cormane et al (7) to be inhibited by both S. aureus and 
S.. albus. It was similarly demonstrated by Prelie that 
28 of 30 strains of Neisseria. gram negative cocci, were 
inhibited by all 10 strains of S. aureus used in his 
studey (29)* Streptococci, including both the hemolytic 
non-hemolytic types other than enterococci, have been reported 
susceptible to the antagonism of Staphylococcus species 
(36). 
Among the protozoa, the blood flukes have been re¬ 
ported to be susceptible to the effects of certain enteric 
bacilli, Klebsiella pneumoniae injected into mice has been 
shown to effectively control Shistosomiasis. Using mice 
with an established infection of Shistosoma mansoni. Ottens 
and Dickerson (27) demonstrated that intraperitoneal in¬ 
jection of K. pneumoniae destroyed the fluke in 3 to 4 days. 
A positive relationship between the multiplication of the 
bacteria in the ceacum and the rapid death of the parasite 
was demonstrated. 
Another group of antagonistic bacteria are the 
streptococci, especially members of the viridans group. 
Sanders (31) demonstrated that Streptococcus pyogenes is 
is antagonized by viridans streptococci. Neither the 
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phase of growth nor the inoculum size affected the in-vitro 
antagonism* While all group A streptococci were inhibited 
by active viridans strains, he reported significant dif¬ 
ferences in the antagonistic capacity of S. viridans. He 
ascribed this to nutrient depletion and accumulation of 
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acidic end products. In-vitro studies of children's throat 
flora was the basis for his hypothesis that the qualitative 
composition of the viridans strains inhabiting the pharynx 
is a major determinant of an individual's resistance to 
group A streptococcal infections. 
Similar observations of the inhibitory capacity of 
the viridans streptococci were made by Sprunt (37)• Evidence 
from 10 patients undergoing massive antibiotic therapy 
indicated the elimination of viridans streptococci and re¬ 
placement with Hemophilus influenzae and yeasts. 
Kalmanson et al (17) using an agar overlay technique 
to demonstrate antagonism were able to effect inhibition of 
microbial L-forms. Emoloying paper discs saturated with 
S. faecalis broth, the discs were placed on a nutrient agar 
base layer. An agar overlay seeded with the L-form organism 
was then applied over the base layer. 
Among the earliest investigations of antagonistic 
interactions were those with Pseudomonas as effector strains. 
Emmerich and Low (8) using spent cultures of Pseudomonas 
found them effective against Bacillus anthracis. Vibrio 
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cholerae. Salmonella typhi, C. diptheriae, Pasteurella 
pestis and a variety of staphylococci. They suggested that 
the agent responsible was the enzyme "pyocyanase." It was 
later determined that several crystalline pigments belonging 
to the phanazine class of compounds were responsible for the 
antagonism observed by the earlier workers (33). Pyocyanine, 
the best known of these compounds, is a blue pigment, 
extractable with CHCl^ and mildly bacteriostatic. Like 
the other phenazine pigments, it has never been used 
clinically as an antibiotic due to its toxicity. 
In light of the present dilemma concerning the use¬ 
fulness and limitations of antibiotics, it is perhaps the 
organism and not the extracted products that deserve greater 
consideration. Pseudomonas, in this regard, has been iso¬ 
lated with regularity from the respiratory tract of healthy 
subjects. Sutter et al (38) recovered this organism from 
6.6% of the oral cavities of 350 normal subjects. The intact 
Pseudomonas cell with its capacity to synthesize a variety 
of phenazine pigments, each with considerable anti-microbial 
activity, might be a significant factor in natural resistance 
to disease. 
That the usefulness of extracted antibiotics produced 
by pseudomonads is limited, was keenly observed by Rosebury 
(30) who stated that "—the search for useful antibiotics 
among indigenous effectors has been entirely fruitless." 
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This seems especially significant when one considers that 
Ps. aeruginosa was the first indigenous microorganism to 
disclose antibiotic effects (7)* Nevertheless, this 
organism, as an effector strain, has the capability to 
produce antibiotics while most indigenous effectors either 
elaborate major metabolites, such as ethanol, or compete 
for vital nutrients. Also significant is the ability of 
Pseudomonas species to synthesize pyocines, which are active 
against other strains of the same species. 
Candida, with its well-known capacity to inhabit 
man as either a pathogen or commensal, is another organism 
which must be included in this consideration of interactive 
phenomena (21). Of particular concern is its widespread 
resistence to antibiotics. The new drugs presently available 
and relatively effective against Candida are Mycostatin and 
Amphotericin B. Mycostatin is limited to superficial 
infections; cases often as effectively treated with po¬ 
tassium permanganate or crystal violet preparations. 
Amphotericin B is used for systemic candidiasis but its 
toxicity severely restricts its usage. For these reasons the 
physician is reluctunt to prescribe these drugs and tends to 
manage a regimen which treats the underlying disease to which 
Candida is often secondary (13* 27)* 
As a participant in microbial interactions, Candida 
is known to exhibit both stimulative and inhibitory effects. 
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The vitamin components and the amino acids elaborated are 
apparently responsible for the stimulatory effect (29). 
Lactobacillus species and Neusseria catarrhalis are known 
to benefit from a wide variety of associations, one of 
which is with C. albicans (30, 42). Escherichia coli is 
similarly stimulated by the presence of C. albicans. 
Candida, on the other hand, is inhibited by its presence. 
Rosebury et y. (30) reported that E. coli grew luxuriantly 
in association with Candida on Douglas Lactate agar. When 
E. Coli was cultivated separately, no growth was observed. 
Inhibition of Candida may be ascribed to competition 
for nutrients. In a study using fresh saliva, sterile and 
contaminated, growth of Candida was determined to be 
directly proportional to the concentration of salivary 
glucose. Peak growth of Candida was observed on sterile 
saliva and could only be induced on contaminated saliva 
if glucose was added (20). However, with the Candida- 
Lactobacillus association, it has been observed that Candida 
inhibition was due to the concentation of excess lactic acid 
and hydrogen ions (42). 
As an antagonist, Candida may produce an antibiotic 
which inhibits N. gonorrhea. Genital tract specimens often 
contain both of these organisms and yet growth of Neisseria 
is often diminished or entirely prevented when in competition 
with Candida, a phenomenon not evident when Candida is absent. 
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An inhibitory factor not yet identified but presumably 
an antibiotic has been extracted with tertiary butanol (14). 
The significance of metabolites such as ethyl 
alcohol as inhibitory agents when synthesized in-vivo has 
not been reported although blood alcohol levels of 0.02$ 
EtOH have been found post mortem apparently synthesized 
by C. albicans (36). 
In the studies of antagonistic interaction it is 
apparent that three possible mechanisms of inhibition may 
be operative: (1) depletion of nutrients essential to the 
associate organism, (2) elaboration of a major metabolite 
with the creation of a restrictive physiological condition 
and (3) synthesis of an antibiotic substance. While any one 
of these may not be difficult to demonstrate in-vitro, the 
evidence for their in-vivo action is indirect and circum¬ 
stantial. 
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MATERIALS AND METHODS 
Organisms 
Most of the microbial cultures employed in this 
study were obtained as fresh clinical isolates. The bac¬ 
terial and yeast strains studied are listed in Table 1 and 
were maintained on slants of Stock Culture agar (Difco), 
at ambient air temperature and transferred monthly. 
The organisms were characterized using standard 
bacteriological tests as described in the Manual of Clinical 
Microbiology by Blair et al (2). All media were freshly 
prepared from a dehydrated base (Difco) and reactivity 
confirmed before use. 
The Candida isolates were initially isolated on 
Tryptose Blood agar (TBA, Difco) and transferred to Sabour- 
aud Dextrose agar (Difco) for separation. After 24 hours 
incubation at 37C, purity was ascertained by visual in¬ 
spection and a single colony used as inoculum for the 
following procedurest germ tube production, BIGGy agar 
(Difco) reaction, carbohydrate utilization, chlamydospore 
production and urease activity. Only those isolates pro¬ 
ducing reactions consistent with C. albicans were retained 
in the culture collection. 
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TABLE 1 
CLINICAL ORIGINS OF EFFECTOR 
AND TEST ORGANISMS 
Effector Strain 
Ps. aeruginosa 69467 
Ps. aeruginosa 69326 
Ps. aeruginosa 68114 
Ps. aeruginosa 100 
Ps. aeruginosa 68084 
Ps. aeruginosa 69616 
Ps. aeruginosa 67650 
Ps. aeruginosa 68394 
Ps. aeruginosa 69376 
Ps. aeruginosa 69322 
Ps. aeruginosa 69386 
Test Strain 
C. albicans 68656 
C. albicans 68443 
C. albicans 67324 
C. albicans 67578 
C. albicans 68340 
C. albicans 67624 
C. albicans 67626 
C. albicans 68236 
C. albicans 68277 
C. albicans 68366 
C. albicans 68298 
C. albicans 68655 
Origin 
respiratory tract 
urinary tract 
respiratory tract 
respiratory tract 
tracheostomy incision 
urinary tract 
respiratory tract 
respiratory tract 
tracheostomy incision 
respiratory tract 
urinary tract 
respiratory tract 
genital tract 
urinary tract 
urinary tract 
respiratory tract 
genital tract 
respiratory tract 
respiratory tract 
urinary tract 
urinary tract 
gastrointestinal tract 
respiratory tract 
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The Pseudomonas isolates were also recovered from 
TBA plates inoculated with clinical material. Colonies 
resembling Pseudomonas were transferred to Meuller Hinton 
agar (MH, Difco) and after 24 hours incubation a single 
colony was used as inoculum for the following determinations: 
reaction in O/F Medium (Difco) containing glucose, motility 
in a hanging drop preparation, ketogluconate exidation (Key 
Scientific) and cytochrome oxidase reaction using p-amino 
dimethylaniline oxalate reagent. Confirmed isolates of 
Ps. aeruginosa were then transferred to the stock culture 
collection for further study. 
Associative Cultures 
Initially the interference phenomenon was observed 
on solid media. Peptone agar plates were inoculated with 
a single diametric streak of Pseudomonas, after 24 hours 
incubation the agar was inverted using the "flip-flop" 
method reported by Kekessey and Piquet (15)• The agar was 
loosened with a sterile spatula and inverted into the lid 
of the petri dish. Candida was then streaked onto the ex¬ 
posed agar surface perpendicular to the original Pseudomonas 
streak. The plate was again incubated at 37 C and the 
inhibition noted. 
A variety of in-vitro techniques, utilizing either 
liquid or solid media, have been devised to demonstrate 
interference among microorganisms (29)* In this phase, 
17 
liquid cultures were utilized in three studies in order to 
evaluate the routine methods employed to demonstrate this 
antagonism. 
The first quantified the growth of Candida on 
sterile spent Pseudomonas broth and also the growth of 
Pseudomonas on similarly prepared Candida broth. A 500 ml 
Erlenmeyer flask containing 100 ml of Brain Heart Infusion 
(BHI, Difco) was inoculated with a BHI culture of Pseudomonas 
aeruginosa 100 that was incubated overnight at 37 C. A 
second flask was similarly inoculated with C. albicans 
67324. Both flasks were incubated for 48 hours as sta¬ 
tionary cultures at 37 C. The spent broths were then 
filter sterilized (Millipore 0.45 mu pore size) and a two¬ 
fold serial dilution extending to 1:128 in 16x150 mm test 
tubes was prepared and inoculated with the alternate 
organism. After 72 hours the organisms in each tube were 
quantified by serial dilution in 0.85$ saline. Blood agar 
pour plates were seeded with 0.1 ml of each dilution and 
incubated for 24 hours at 37 C. Results are presented as 
arithmetic means of duplicate counts and expressed as colony 
forming units per ml (CFU/ml). 
In the second trial, Ps. aeruginosa 100 and C. 
albicans 67324 were inoculated into separate flasks, 1 ml 
of an overnight BHI culture was added to 200 ml of BHI and 
incubated at 37 C for 24 hours. The flasks were then cross 
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inoculated with the alternate organism using 1 ml of an 
overnight BKI culture. The flasks were sampled at 24, 48, 
72 hours and 6 days. Cne-tenth ml of each was used as 
inoculum for duplicate "blood agar plates. After 24 hours 
incubation at 37 C the plates were examined qualitatively 
for the presence of Pseudomonas and Candida. 
The third trial consisted of three 500 ml Erlenmeyer 
flasks each containing 100 ml of BHI broth. The first flask 
was inoculated with 1 ml of Fs. aeruginosa 100 standardized 
to contain 25 cells per ml. The second flask was inoculated 
with C. albicans standardized to contain 24 cells per ml. 
The third flask received 1 ml each of the Pseudomonas and 
the Candida standardized inocula. The flasks were incubated 
at 37 C for 30 days and sampled at regular intervals. Ten- 
fold serial dilutions ranging from 1x10"^ to 1x10” were 
made and smeared onto KH agar and Molybdate Agar plates 
(Hospital Service Technology, North Andover, Mass.) for 
quantification (expressed as CFu/ml). 
Overlay Technique 
Detection of interference in liquid cultures proved 
to be an unwieldy technique. This difficulty was overcome 
by adopting the agar overlay method, the virtue of which lies 
in its simplicity and sensitivity. The first method employed 
was that of Osman's (26) which utilized a 6 ml nutrient 
base layer in a standard petri plate covered with 3 nil of 
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serai-solid {0.67%) agar previously seeded with two drops 
of an overnight broth culture of the test organism. The 
medium after solidification was placed in an incubator 
at 37 C for 90 minutes to dry. Drops of filtrate from 
effector strains of antagonistic microorganisms were placed 
on the surface and when dry, the plates were inverted and 
incubated at 37 C overnight. This technique lacked sensi¬ 
tivity to detect weakly antagonistic effector strains and 
was modified after the following studies were completed. 
1. Base layer components. Three modifications were 
examined for enhancement of overlay zone development. The 
first compared nutritionally complete MH medium to Nutrient 
agar (NA, Difco). Ten ml of each medium were pipetted into 
standard petri plates and after hardening, 3 ml of 0.8% 
agar was used for the overlay. The second examined the 
effect of pH ranging from 4 to 8. Acid reactions of pH 4 
and 6 were prepared by adding 2 N tartaric acid dropwise 
to sterile liquid (40 C) medium. Alkaline media with a 
pH reaction of 8 was prepared by the addition of 1 N 
sodium hydroxide. Ten ml of each adjusted preparation were 
pipetted into standard petri plates, allowed to harden, and 
the agar overlay applied as before. The third utilized five 
different base layer volumes of MH agar (5» 10» 15» 20 and 
25 ml per plate). After hardening, a 3 ml agar overlay 
was applied. 
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In all of the above, the overlay consisted of 0.8% 
bacteriological grade agar prepared in 100 ml of distilled 
water seeded with 1 ml of an overnight broth culture of 
C. albicans 67324. When solidified, the overlay surface 
was spotted dropwise with sterile spent broth of Ps. 
aeruginosa 100. After overnight incubation at 37 C, zones 
of inhibition were measured with metric calipers. 
2. Filtrate application and overlay agar volume. 
Using a base layer of MH agar (10 ml), both 3 and 6 ml 
volumes of overlay agar were compared for zone development. 
C. albicans 67324 was seeded as before and the agar allowed 
to solidify. Using a microliter syringe (Hamilton Model 
710-LT, The Hamilton Co., Reno, Nevada), 10, 20, 3°» 40 
and 60 microliter volumes of filtrate were applied to the 
plates prepared with 3 nil of overlay agar. All plates 
were incubated overnight at 37 C and zones of inhibition 
measured. 
3* Effector strain filtrate. Two hundred ml 
of BHI broth contained in a 500 ml Erlenmeyer flask was 
inoculated with 1.0 ml of an overnight BHI broth culture 
of Ps. aeruginosa 100 and incubated at 37 C for 14 days 
as a stationary culture. A very viscous gel accumulated 
during this time which required primary filtration with 
coarse Whatman No. 1 rapid flow filter paper prior to 
membrane filter sterilization (Millipore, 0.45 urn pore 
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size). The resulting preparation, unless used immediately, 
was stored at -20 C. 
To replenish the supply of filtrate, the preparation 
procedure was repeated at regular intervals throughout the 
experimentation. A pool was established and all filtrate 
/ 
harvested was added to it; the pool was labeled "Pool X." 
As needed, the pool was thawed at room temperature and an 
aliquot removed. The pool was then promptly refrozen and 
maintained at -20 C. 
4. Modified overlay technique: final version. 
Ten ml of MH agar was poured into standard petri plates 
and allowed to solidify. Then 3 ml of 0.8$ bacteriological 
grade agar seeded before solidification (40 C) with 1 drop 
of an overnight BHI broth culture of Candida albicans was 
used as the overlay. This layer was allowed to set and dry 
with the petri plate cover slightly ajar for 30 minutes at 
room temperature. Drops of Pseudomonas filtrate prepared 
as previously described on sterile blank paper discs (BBL, 
Baltimore, Md.) saturated with filtrate were applied to 
the surface. The plate covers were left slightly ajar 
until the filtrate had dried, then the covers were closed 
and the plates incubated at 37 C overnight. Zones of 
inhibition were measured in millimeters diameter. 
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Characterization of the Antagonistic Phenomenon 
Using the overlay technique, further studies of the 
antagonistic phenomenon were implemented to characterize 
the Candida-Pseudomonas interaction and to ascertain the 
conditions which enhance the antagonism of Pseudomonas 
and the susceptibility of Candida* Also explored was the 
antagonistic effect of Pseudomonas on other microbial 
species. 
1. Interaction: variation among strains. The 
Pseudomonas and Candida strains listed in Table 1 were 
screened to select those exhibiting maximum interference. 
The 11 strains of Pseudomonas and 12 strains of Candida were 
evaluated as effector and test strains, respectively. The 
degree of interference was judged on a scale of 0 to 3 to 
facilitate the selection process. The test and effector 
strains selected were used exclusively in the studies that 
followed. 
2. Antagonistic spectrum toward other microbial 
species. Eleven fresh clinical isolates, randomly selected 
to serve as test organisms for Pseudomonas, were inoculated 
into sterile BHI broth (8 ml) and incubated overnight at 
37 C. These test species included: Ps. iodium, S. viridans, 
S. pyogenes, S. Faecalis, S. aureus, E. coli, Herella vagini- 
cola, Proteus mirabilis, K. pneumoniae and C. albicans♦ 
One drop of each broth culture was added to 3 ml of overlay 
agar in the procedure that followed. 
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3* Conditions favoring the production of active 
filtrate. This series of experiments examined the condi¬ 
tions which enhanced the antagonistic effect of Pseudomonas. 
Three 250 ml Erlenmeyer flasks containing 25, 50 and 150 ml 
of BHI broth were prepared and inoculated with 1 ml of an 
overnight BHI broth culture of Ps. aeruginosa 100. The 
flasks were incubated as stationary cultures at 37 C and 
3 ml aliquots were harvested at the following times: 1, 2, 
4, 6, 9, 12, 14 and 20 days. The aliquots were sterilized 
by membrane filtration and assayed using the overlay tech¬ 
nique previously described. As in all of the procedures 
that follow, only discreet zones of complete inhibition 
were measured and recorded. 
Incubation temperature variables were evaluated to 
establish the optimum for inhibitory activity. Three 500 
ml Erlenmeyer flasks each containing 100 ml of BHI broth 
were inoculated with 1 ml of an overnight broth culture 
of Ps. aeruginosa 100 and incubated for 14 days at 30» 34, 
and 37 C. Aliquots were harvested, filtered and assayed 
using the overlay technique. 
The formulation pH of BHI broth (7.4) was compared 
to adjusted levels of pH 6.4 and pH 5*4 to ascertain its 
effect on spent broth activity. Three 500 ml Erlenmeyer 
flasks each containing 200 ml of BHI broth were adjusted 
to the desired pH using 2 N tartaric acid. They were each 
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inoculated with 1 ml of an overnight BHI broth culture 
of Ps. aeruginosa 100 and incubated at 37 C for 14 days. 
After harvesting, the sterile filtrate was assayed for 
activity using the overlay technique. 
Five media were evaluated for their potential as 
spent broth substrates* BHI {0,2% glucose), BHI (1.0% 
glucose), Pseudomonas F broth, Pseudomonas P broth and Nutri 
ent broth (Difco)j the latter three media contained no 
glucose. One hundred ml volumes of each were prepared in 
500 ml Erlenmeyer flasks and inoculated with 1.0 ml of an 
overnight broth culture of Ps. aeruginosa 100 BHI. The 
flasks were incubated for 14 days at 37 C, harvested, 
filtered and assayed for activity. 
4. Candida susceptibility as a function of 
incubation time. Two 500 ml Erlenmeyer flasks each con¬ 
taining 100 ml of BHI broth and inoculated with 1 ml of 
an overnight BHI culture of C. albicans 67324 were pre¬ 
pared. One flask was incubated for eight days and the 
other for one day. Both flasks were harvested, filtered 
and assayed simultaneously. The standard overlay procedure 
was followed. 
Characterization and Purification of the Active Principle 
1. Cell free extract. Ps. aeruginosa cells grown 
in 1300 ml of BHI broth for 5 days at 37 C were harvested 
by centrifugation at 8000 x g for 10 minutes in a Sorvall 
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RC-2B refrigerated centrifuge. The supernatant was dis¬ 
carded and the pellet of cells suspended in distilled 
water, 0.1 g (wet weight)/ml. The suspension was disrupted 
by 5 minutes of sonic oscillation (Biosonic, Bronwill 
Scientific Co.). The preparation was then passed through 
a French pressure cell (Wabash Metal Products, Wabash, 
Indiana) at 5000 lb/in after which the cell debris was 
removed by centrifugation at 6500 x g. The supernatant 
was retained for assay of anti-candidal activity. 
2. Dialysis. Spent broth was dialyzed using two 
types of membrane tubing: natural cellulose (Fisher 
Scientific, Pittsburgh, Pa.) which retains molecules with 
a molecular weight exceeding 12,000 and regenerated cellu¬ 
lose (Fisher Scientific) retaining molecular weights ex¬ 
ceeding 3,500. Twenty ml of filtrate (Pool X) added to 
each dialysis sac was dialyzed for 24 hours in 500 ml of 
distilled water at 6 C. Aliquots were removed and spotted 
on overlay agar along with an untreated sample. 
3* Trypsinization. One ml of freshly prepared 
5$ trypsin (Schwarz/Mann, lot #3910) was added to 9 ml 
filtrate (Pool X) and incubated at 37 C for 24 hours. 
Another 9 ml of filtrate with 1 ml of saline added, in¬ 
stead of trypsin, served as a control sample. The 
preparations were assayed using the standard overlay 
technique. 
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4. Thermal stability. The heat stability of the 
inhibitory compound produced by Pseudomonas was evaluated 
after heating aliquot6 of filtrate at 56» 68, and 100 C 
for 45 minutes and storing at 6 and -20 C for 12 days. 
5. Stability to acid, light and desiccation. A 
1.0 ml aliquot of filtrate (Pool X) was treated with IN 
H2S0^ until pH 5 was obtained. After 15 minutes, 0.5 ml 
was removed and neutralized with 2 N NaOH to pH 8 and 
held for 15 minutes. An untreated aliquot of filtrate 
pH 8.3 (natural pH) served as a control sample. All 
preparations were then assayed for activity. 
Stability to light and desiccation was determined 
by spotting cellulose polyacetate electrophoresis strips, 
1" X 6" (Gelman Instrument Co., Ann Arbor, Michigan), with 
30 microliters of filtrate. The strips were allowed to 
dry and remain exposed to the air and artificial light of 
the laboratory for five days. After exposure, the strips 
were appressed to the overlay agar surface along with 
control strips spotted with fresh filtrate. After incu¬ 
bation overnight at 37 C, the strips were removed and the 
plates re-incubated for 24 hrs for further growth of 
Candida. 
6. Zone electrophoresis. Separation of the 
bio-active principle was attempted by electrophoresis on 
cellulose acetate strips (Sepraphore III) using an electro- 
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phoresis chamber (Gelman Instrument Co., Ann Arbor, 
Michigan). Twenty microliter samples of Pseudomonas fil¬ 
trate (Pool X) were applied to the strips and allowed to 
dry. The strips were moistened in buffer and stretched 
across the chamber. A 0.25 microliter sample of RBY 
reference dye solution (Gelman Instrument Co.) was then 
applied to one end of a control strip and 175 volts were 
applied to the system for 45 minutes. The strips were 
removed and cut in half, each piece was then appressed to 
the surface of a freshly seeded C. albicans overlay agar 
plate and incubated for 24 hours at 37 C. The strips were 
then removed and the plates reincubated for an additional 
24 hours to enhance the growth of Candida. 
7* Extraction technique. To determine the polar 
nature of the active agents responsible for inhibition of 
Candida, three organic solvents were used. Nine 100 ml 
extraction flasks, each containing 20 ml of filtrate (Pool 
S) were divided into three groups. The first group was 
adjusted to pH 3* and the second to pH 7 using IN H^SO^. 
The third group was adjusted to pH 9 using 2 N NaOH. The 
solvents used were hexane, diethyl ether and butanol 
(analytical grade). Twenty ml portions of each solvent 
were added to one flask of each group and after 2 minutes 
of hand shaking, the phases were allowed to separate. The 
aqueous phase was retained and extraction repeated, after 
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which the aqueous phase was separated, placed in a petri 
dish and allowed to air for 30 minutes. The nine prepara¬ 
tions were then assayed for residual activity. 
A second extraction scheme was followed using only 
chloroform as the solvent. Six ml of filtrate, adjusted 
to pH 2 using 6 N HC1 were extracted with 6 ml of CHCl^. 
The CHCl^ phase, after separation, was evaporated for 3 
hours in a watch glass containing 4 blank paper discs. 
The aqueous phase remaining after extraction was adjusted 
to pH 10 using 6 N NaOH and extracted again with CHCl^. 
The discs were then assayed for activity using the overlay 
technique. 
The third approach to the selection of solvents 
was based on the observation of crystalline inclusions 
within colonies of Pseudomonas cultured on MH agar. After 
4 to 6 days incubation, the agar plates were examined under 
low microscopic magnification (100 X), various organic 
solvents were added and dissolution of the crystals was 
noted. 
The information gained from these preliminary studies 
prompted the investigation to follow an extraction scheme 
for the phenazines (Fig. 1) as reported by Chang and 
Blackwood (5)« Ten microliters of extract were spotted on 
thin-layer chromatography plates coated with 0.25 mm of 3IL 
G-25 silica gel without gypsum (Brinkman Instruments, 
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Pyocyanine Phenazine-1- 
carboxylic acid 
Fig. 1. Scheme for Separation of Two Phenazine Pigments. 
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Westbury, N.Y.). The bands were compared to reference 
pigments simultaneously chromatographed. 
Identification Techniques 
The band corresponding to Pyocyanine was re- 
chromatographed and eluted as previously described. This 
was followed by crystallization from cold CHCl^ with the 
addition of petroleum ether. The melting point of the 
crystalline product was obtained with a microscope and a 
Kofler hot stage apparatus. The absorption maxima of the 
product in 0.2 N HC1 was measured on a Beckman DU model 
2400 spectrophotometer. Both reference and isolated com¬ 
pounds were developed on Brinkman thin layer chromatograms 
/ 
using CHCiy.leOH solvent mixture (9si) and their rf values 
compared. 
The band corresponding to phenazine-l-carboxylic 
acid was rechromatographed and eluted with 0.1 M NaOH. 
A melting point determination using a capillary tube 
apparatus was attempted, however, after reaching 360 C the 
product was presumed to be a salt. After redissolving in 
6 N HC1 and extracting with CHCl^ the preparation was 
allowed to evaporate. The pigment was then crystallized 
from cold MeOH and the melting point with a correction 
factor of 0.5 C was successfully determined. The crystalline 
appearance was compared to authentic samples of phenazine- 
l-carboxylic acid. The absorption maxima were measured in 
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0.2 N HC1. Following this the sample was chromatographed 
along with authentic samples using the same TLC procedure 
as described above for pyocyanine. 
Biological activity of all bands was verified by 
scraping from the thin-layer chromatogram visualized with 
an ultraviolet lamp (Blak-Ray, model UVL-22, 366 nm wave¬ 
length, Ultraviolet Products, Inc., San Gabriel, Calif.). 
The scrapings were collected in a pasteur pipette packed 
with a small quantity of acid-washed glass wool to prevent 
loss of the powder. The band corresponding to pyocyanine 
was eluted with 0.1 N HC1 while that corresponding to 
phenazine-l-carboxylic acid was eluted with 0.1 N NaOH. 
Each eluate was absorbed on three blank paper discs and 
when dry were assayed for inhibitory activity using the 
standard overlay technique. Inhibition zones were com¬ 
pared to those obtained with authentic pyocyanine and 
phenazine-l-carboxylic acid. Both reference compounds were 
prepared in four concentrations (250, 25» 2.5 and 0.25 
mcg/ral) in 0.1 ml of 0.1 N NaOH and added dropwise to the 
overlay agar surface. 
Reference Compounds 
Pyocyanine was purchased from Schwarz Mann, 
Orangeburg, N.Y. Phenazine-l-carboxylic acid was a gift 
from Frederick Helliman, Department of Organic Chemistry, 
the University of Leeds, Leeds, Scotland. The organic 
solvents and other chemicals used were analytical grade. 
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RESULTS 
Overlay Technique 
Five variables were examined in the development of 
this technique and are summarized in Table 2. It can be 
seen that acidification of the base layer resulted in 
complete loss of inhibitory activity. On the other hand, 
MH medium at pH 7.4 induced a larger inhibitory zone than 
that obtained at pH 8.0. 
The overlay agar and base layer volumes were in¬ 
versely proportional to the resulting zone size. Some 
difficulty was experienced in preparing a 3 ml overlay of 
uniform depth. The problem was alleviated by pouring the 
overlay shortly after the base layer had solidified and was 
still warm. The volume of filtrate applied appeared to be 
stoichio-metrically related to the inhibition zone obtained. 
Results of the media evaluation indicated that the more 
enriched MH agar induced larger zones of inhibition than 
those obtained with nutrient agar. 
Conditions for Interaction 
As revealed in Table 3» serial dilution of inhi¬ 
bitory filtrate was accompanied by a progressively increased 
growth response by C. albicans. On the other hand, Ps. 
aeruginosa exhibited a diminished growth response in serial 
dilution of C. albicans filtrate. These findings indicate 
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TABLE 2 
OVERLAY TECHNIQUE VARIABLES AND THEIR EFFECT 
ON INHIBITION ZONE DEVELOPMENT 
Variables evaluated Inhibition zone 
pH (base layer) 
4.0 0 
6.0 0 
7.4 15.7 
8.0 13.6 
Overlay volume (ml) 
3.0 9.1 
6.0 6.0 
Base layer volume (ml) 
5-0 20.8 
10.0 17.0 
15.0 14.5 
20.0 11.0 
25.0 8.5 
Filtrate volume (ul) 
10 0 
20 6.0 
30 8.5 
40 12.0 
60 14.5 
Medium 
KH 15.7 
Nutrient agar 13.1 
a Zone diameter in millimeters. 
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TABLE 3 
EFFECT OF FILTRATE DILUTION ON 
GROWTH OF ASSOCIATE ORGANISM 
Reciprocal of 
filtrate dilution 
Plate counts 
Candida (CFU 10^) Pseudomonas (CFU 10^) 
2 6.0 146.5 
4 14.0 8O.5 
8 36.5 75.0 
16 32.0 53.5 
32 35.0 62.5 
64 46.5 57.5 
128 63.0 55.5 
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that in associative cultures, Candida is inhibited while 
Pseudomonas is stimulated. 
The intent of this study was to determine whether 
the inhibitory activity of the filtrate was due to the 
development of physiological and chemical changes (in¬ 
cluding substrate depletion) in spent broth or the 
elaboration of an antibiotic substance. Since the serial 
dilution of the spent broth was accompanied by a commen- 
f 
surate growth response of Candida, it was hypothesized 
that an antibiotic substance was responsible for the in¬ 
hibition. 
The second experiment examined the effect of 
inoculating each species into established cultures of the 
alternate species (Table 4). While Ps. aeruginosa was 
capable of establishing itself in an actively growing 
culture of C. albicans, Candida could not be established 
in an actively growing culture of Ps. aeruginosa. 
To further confirm this antagonistic interaction, 
growth curves of the two organisms growing separately and 
together were plotted. In this case the mixed culture was 
established by simultaneous inoculation, a method outlined 
by Guze, et (?). As can be seen in Fig. 2, C. albicans 
survived but exhibited a diminished population when com¬ 
pared to growth in pure culture. The foregoing studies 
suggest that Candida, if given time to establish 
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TABLE 4 
ISOLATION OF C. ALBICANS AND PS. AERUGINOSA 
FROM ASSOCIATIVE CULTURES ORIGINALLY 
ESTABLISHED WITH A SINGLE SPECIES 
Time after Culture 
Organism recovered 
assoc, culture 
inoculated 
originated 
as s 
C. albicans Ps. aerug. 
1 day Candida 
Pseudomonas 
+a + 
+ 
2 days Candida 
Pseudomonas 
+ + 
+ 
3 days Candida 
Pseudomonas 
+ + 
+ 
6 days Candida 
Pseudomonas 
+ + 
+ 
a+ growth 
- no growth 
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TIME- DAYS 
Figure 2, Growth of C. al bi cans alone and 
in the presence of Ps_. aerugi nosa , 
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Figure 3 Growth of Ps, aeruginosa alone and 
in the presence of C. albicans . 
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logarithmic growth can adapt to the introduction and 
development of Pseudomonas. 
The antagonistic spectrum of Pseudomonas toward 
randomly selected organisms is shown in Table 5. The 
diversity of susceptible organisms further supports the 
hypothesis that the active principle was an antibiotic and 
not a bacteriocin or a phage. 
The survey of conditions optimum for the yield of 
the hypothesized antibiotic indicated that the incubation 
time for stationary cultures must extend beyond 4 days 
(Table 6). The highest yield was obtained from a 14 day 
old culture although activity was still detectable at 20 
days. These findings are similar to those of other workers 
who reported that old cultures of Pseudomonas were highly 
"bacteriocidal" to many organisms (39» 4l). Also shown in 
Table 6 is the correlation between yield and medium volume. 
Since no activity was observed in the very shallow (25 ml) 
culture flask, it appears that the redox potential may 
influence the synthetic pathway of the antibiotics. 
The data in Table 7 show that of the 3 temperatures 
evaluated for the incubation of Pseudomonas, 30 C yielded 
the most potent filtrate. Approximately 84$ of this 
activity was detected at 34 C and only 50$ at 37 C. These 
observations are in accord with those made by Chang and 
Blackwood while investigating the phenazine pigment (5)» 
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TABLE 5 
ANTIMICROBIAL SPECTRUM OF 
PSEUDOMONAS FILTRATE 
Test Organism Range Mean2 
Candida albicans 14-I5b 14.4 
Escherichia coli 14-16 15.0 
Herellea vaginicola 12-13 12.6 
Klebsiella pneumoniae 0 0 
Froteus mirabilis 16-1? 16.8 
Pseudomonas iodinium 0 0 
Staphylococcus aureus 15-17 16.0 
Streptococcus faecalis 0 0 
Streptococcus pyogenes 0 0 
Streptococcus viridans 0 0 
aZone diameter of five replicate plate counts. 
^Zone diameter in millimeters. 
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TABLE 6 
THE EFFECT OF INCUBATION TIME AND MEDIUM VOLUME 
ON THE DEVELOPMENT OF FILTRATE POTENCY 
Incubation 
Time 
Medium Volume 
(days) 25 ml 50 ml 150 ml 
1 0 0 0 
2 0 0 0 
4 0 indiscreet zones 
6 0 7.8a 7.0 
9 0 7-7 9.1 
12 0 5.6 7.4 
14 0 8.6 10.9 
20 0 6.2 8.4 
a Zone diameter in millimeters. 
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TABLE 7 
THE EFFECT OF INCUBATION TEMPERATURE ON 
FILATRATE POTENCY DEVELOPMENT 
Pseudomonas Incubation Range Mean 
Temperature C 
30 13-l6a 15.2 
34 10-14 12.8 
37 5-io 7.2 
Q 
Zone diameter in millimeters. 
Kluyver (19) made a similar observation in his studies 
using Ps. aureofaciens as the effector strain. He noted 
that 30 C was optimal for both growth and pigment (anti¬ 
biotic) production, while 35 C yielded satisfactory growth 
but no detectable pigment. 
No difference in activity was noted in the filtrate 
prepared from BHI broth adjusted to pH levels of 5*^» 6.4 
and 7*4. On the other hand, evaluation of various media 
and the resultant filtrate activity revealed that only 
BHI broth yielded detectable inhibition. While it has 
been reported that glucose or glycerol in concentrations of 
1-8$ are necessary for quantity production of the phenazine 
pigments (9)* it should be noted that none of the other 
media contained carbohydrate. 
The final condition examined was the effect of 
incubation time on the susceptibility of C. albicans to 
pseudomonas pigments. Table 8 shows three growth phases 
of Candida (exponential, stationary and death) which were 
used to seed the agar overlay. While there was essentially 
no difference in the data obtained between the stationary 
and death phases, the susceptibility in the exponential 
phase was approximately 10$ less than that of the stationary 
phase. This observation substantiates the data obtained 
from associative cultures showing the adaptability of 
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TABLE 8 
THE RELATIONSHIP BETWEEN INCUBATION TIME 
OF C. ALBICANS AND ITS SUSCEPTIBILITY 
TO PSEUDOMONAS FILTRATE 
C. albicans 
Growth Phase Range 
Susceptibility 
Mean 
Exponential 
24 hrs. 
14-I7a 15-5 
Stationary 
48 hrs. 
17-18 170 
Death 
28 days 
17-19 17.6 
a Zone diameter in millimeters. 
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Candida in its early growth phases. 
Agents Responsible 
While the foregoing results of interactive phenomena 
seem to indicate that an antibiotic agent was responsible, 
more conclusive evidence was established upon the completion 
of the extraction and purification techniques. Character¬ 
ization prior to these techniques showed that the active 
principle in the filtrate was not an enzymatic or protein¬ 
aceous agent. Trypsinization did not affect the bioactivity 
nor did any of the thermal treatments. The substance was 
stable on exposure to light and dessication and the molecular 
weight as indicated by dialysis was less than 3»500. 
Definitive data were not obtained from studies using cell- 
free extract nor was the separation technique using zone 
electrophoresis successful. Neither investigation was 
pursued further and the data are not presented. 
The activity was completely lost on acidification 
of the filtrate to pH 5» After reversal to 8.3 (original 
pH), activity was restored and comparable to the untreated 
control sample. These findings supported the observations 
made in the development of the overlay technique where an 
acid pH base layer completely neutralized antibiotic 
activity (Table 9)» 
Crystalline inclusions within colonies of Pseudomonas 
growing on MH agar proved to be soluble in CHCl^# sparingly 
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soluble in butanol and not soluble in hexane as observed 
by microscopic examination (100 X). 
The extraction scheme of Chang and Blackwood 
yielded two bio active products: (1) deep blue rhembic 
crystals soluble in CHCl^ and hot water, consistent with 
pyocyanine and (2) yellow, needle-like crystals, soluble 
in CHCl^ and alkali, consistent with phenazine-l-carboxylic 
acid. Although a number of other spots were observed 
when these crude extracts were chromatographed only these 
two compounds were active against C. albicans. The 
physiochemical properties obtained after the final 
crystallization are compared with authemtic samples 
(tables 10,11). As; can be seen, both the isolated and the 
reference compounds behaved identically. As further proof, 
derivatives were prepared. A semi-carbazone from pyocyanine 
and an amide from phenazine-l-carboxylic acid showed rf 
values similar to derivations of the isolated pigments. 
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TABLE 9 
THE EFFECT OF ACIDIFICATION ON THE 
DEVELOPMENT OF FILTRATE POTENCY 
pH manipulation 
Inhibition 
Range 
zone 
Mean 
8.3 5.0 no inhibition no inhibition 
8.3 5.0 8.3 16 - 20a 18.6 
8.3 (control 18 - 21 19.6 
a 
Zone diameter in millimeters. 
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TABLE 10 
PROPERTIES OF EXTRACTED AND AUTHENTIC 
PYOCYANINE PIGMENT 
t 
Isolated 
pigment 
Authentic 
pyocyanine 
Appearance dark blue 
needles 
dark blue 
needles 
Melting point C 
with correction 
factor 0.5 C 
132-132.5 132-132.5 
Absorption maxima 
mu in 0.2 N HCL 390, 278 390, 279 
Solubility 
CHCly hot water CHC13, hot 
water 
TLC* rf •55 •55 
TLC: rf deriv. 
semi-carbazone .65 • 63 
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TABLE 11 
PROPERTIES OF EXTRACTED AND AUTHENTIC 
PHENAZINE-l-CARBOXYLIC ACID 
/ 
Isolated Authentic 
pigment pigment 
Appearance yellow needles yellow needles 
Melting point C 
with correction 
factor 0.5 C 
239 239 
Absorption maxima 
mu in 0.2 N HCL 368, 253 368, 251 
Solubility CHCly NaOH CHCl^, NaOH 
TLC: rf .68 .66 
TLC: rf deriv 
carboxamide .61 .61 
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DISCUSSION 
This investigation commenced with the observation 
in the clinical laboratory that colonization of the 
respiratory tract by both Pseudomonas aeruginosa and 
Candida albicans rarely occurred. Coexistence, when ob¬ 
served, was for a brief interval. Ultimately however, one 
species would be pre-empted by the other; moreover, the 
succession of species was observed to progress with 
predictability from Candida to Pseudomonas. 
During the past two decades, these organisms have 
come to be recognized as opportunists and are being isolated 
with increasing frequency from the immunologically in¬ 
competent or "compromised" host. The unfavorable prognosis 
given patients suffering from infections caused by these two 
species arises from the lack of effective antimicrobial 
agents and not from their inherent virulence. Treatment, 
in many cases, is based on resolution of an underlying 
disease or condition which generally accompanies these in¬ 
fections. The possibility of manipulating antagonistic 
interaction between these two organisms and its benefit was 
an exciting prospect and prompted the present investigation. 
The appearance of antagonism on culture plates of 
clinical material is a common laboratory observation. 
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Clinical specimens rarely yield growth of a single or¬ 
ganism; pathogens are often accompanied by indigenous 
"contaminants" and culture plates incubated for 72 hours 
reveal a microbial flora distinctly different from that 
seen after 24 hours incubation. Overgrowth of slower 
growing species, the predominance of one species over 
another and the effect of antibiotic therapy all contribute 
to the phenomenon of apparent antagonism. However, when 
the preliminary observation of antagonism between Pseudo¬ 
monas and Candida was made these factors were discounted. 
The colonial characteristics of Candida and Pseudomonas 
are strikingly different and in mixed cultures their 
presence would be evident. Both organisms grew readily on 
simple media, producing distinct colonies after 24 hours 
incubation. Since Candida is relatively resistant to 
antibiotics, its suppression by these agents in clinical 
specimens would be unlikely. 
From these preliminary observations it was proposed 
that Pseudomonas was antagonistic towards Candida. The 
associative culture studies indicated that the inhibition 
of Candida was due to an antibiotic agent and not to 
nutrient depletion or restrictive physiological conditions. 
The "flip-flop" technique further confirmed this contention. 
Since there was no direct contact between Candida and 
Pseudomonas, the possibility that inhibition was due to 
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phage particles was discounted. 
The next observation was the appearance of 
crystalline inclusions within colonies of Pseudomonas using 
low microscopic magnification. Various organic solvents 
were added dropwise to these colonies to ascertain the 
solubility of the crystals. Chloroform was found to be a 
very effective solvent for these crystals. 
The experiments conducted during the filtrate 
preparation stage of this study revealed that several anti¬ 
biotic pigments were produced during extended cultivation 
of Ps. aeruginosa. At least two of these pigments were 
found to be inhibitory to C. albicans and belonged to the 
phenazine series of compounds. 
It was determined however, that the yield of these 
pigments could be more readily obtained from liquid cultures. 
Stationary flasks incubated at 37 C for 2 to 4 days showed 
development of a deep blue-green pigment in the upper layers 
of the broth. When the incubation was continued for 14 
days, the bottom layer became greenish-yellow until finally 
a yellow-brown color developed throught the medium. At 
the same time, a very evident intractable slime developed 
throught the medium which disintegrated to some extent 
during the extraction process. Nevertheless, it must be 
removed by coarse filtration prior to membrane sterliza- 
tion. 
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The bioactive phenazine pigments obtained by 
extraction were identified as phenazine-l-carboxylic acid 
and pyocyanine. These pigments were readily separated in 
the extraction process by manipulating the pH of the spent 
medium (generally 8.0 to 8.5 after 14 days). After acidifi- 
cation of the aqueous phase to pH 2.0, phenazine-l-carboxylic 
acid formed a precipitate which was soluble in CHCl^. 
Pyocyanine, on the other hand, formed an insoluble pre¬ 
cipitate when the medium was made alkaline (pH 9) and 
could be extracted with CHCly 
Chromatographic separation at this point revealed 
both extracts to be heterogeneous. The extract containing 
pyocyanine, developed on TLC plates, was accompanied by 
six other bands as detected by ultraviolet light. That 
containing phenazine-l-carboxylic acid was accompanied by 
seven other bands. Bromcresol-blue spray, used to detect 
carboxylic acids, was applied to developed plates and a 
positive reaction indicated the position corresponding to 
phenazine-l-carboxylic acid. The organic nature of these 
compounds was confirmed by charring with concentrated 
sulphuric acid and heat. Of all the bands produced, these 
two were among the most prominent and when eluted were the 
only ones exhibiting detectable antagonism towards Candida. 
Though bioactivity was not detectable in the remaining 
bands, it is possible that several other phenazines were 
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present. Their concentration was perhaps too low to be 
detectable by the assay method used. 
Presently, about 3° phenazines have been isolated 
from natural sources. A literature search disclosed that 
although pseudomonads are the most prominant source known; 
Actinomycetes, algae and other diverse species synthesize 
these compounds (1). It has further been shown that anti¬ 
biotic effects are common with the phenazines and the 
mechanism of action appears due to intercalation with 
deoxyribonucleic acid (13)• 
The biosynthetic pathway of the phenazines has 
been elucidated by Hellstein (12). When radioactive labeled 
shikimic acid was supplied to Ps. aeruginosa, 9% was 
incorporated into phenazine-l-carboxylic acid and 7$ into 
pyocyanine. The structural formulas for these two compounds 
is shown in Fig.4 • 
The biological activity of these two phenazines 
{ 
was found to be pH dependent. Under acid conditions, 
phenazine-l-carboxylic acid was apparently insoluble and 
biologically inactive whereas the sodium salt of this acid 
possessed marked activity, the inhibition zones produced 
by the salt were distinctly clear with a discreet periphery 
and could be accurately measured. Furthermore, elution of 
this compound from silica gel of the TLC plates was readily 
accomplished with methyl alcohol containing 1 fo NH^OH or 
COOH 
N» 
PHENAZINE 1 CARBOXYLIC ACID 
PYOCYANI NE 
Figure It. Structural formulas of phenazine-l-carboxyli 
acid and pyocyanine. 
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0.1 N NaOH while methyl alcohol or CHCl^ alone were not 
nearly as effective. 
Pyocyanine is considered a neutral compound and 
its bioactivity as a function of pH was not as evident as 
that seen with phenazine-l-carboxylic acid. Methyl alcohol 
and CHCl^ were both good solvents. Inhibition of Candida 
as observed on overlay agar plates was less evident than that 
seen with phenazine-l-carboxylic acid. Within the inhibition 
zone Candida1s presence was obvious. The inhibition zones 
of both compounds were examined under low magnification 
(100 X) and Candida cells were readily observed: the cell 
population was greater in the case of pyocyaine and budding 
was more obvious. When these zones were subcultured on 
fresh Sabourauds Dextrose agar, growth with original 
vitality was regained. This suggests that in the case of 
Candida these compounds are fungi-static. Moreover, with 
weak or dilute preparations, inhibition was difficult to 
detect or was entirely overlooked. 
When filter paper discs were impregnated with these 
compounds and the discs placed in close proximity on the 
overlay agar surface, approximately two centimeters apart, 
a reinforcing effect was observed (Fig. 4). The asymmetric 
inhibition pattern had the appearance of synergism, although 
this was not investigated further. The area around pyocya¬ 
nine was virtually without affect except where influenced 
by phenazine-l-carboxylic acid. 
58 
Fig. 5. Apparent synergism between phenazine-1- 
carboxylic acid and pyocyanine. Note the asymmetric zone 
of inhibition around the central disc containg phenazine-1 
carboxylic acid caused by the nearest satellite disc con¬ 
taining pyocyanine. 
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Another consideration was the biological activity 
of these phenazines in-vivo and its relationship to pH. 
Since antagonism appears to be dependent on an alkaline 
environment, it is conceivable that interaction might not 
take place in the oral cavity or the vagina when these 
habitats are excessively acidic (28). The in-vitro 
data at pH 6.0 and below showed complete loss of anti- 
candidal activty (Table 2). The concentration of serum 
glucose and its conversion by the indigenous flora to acid 
end-products may be the major determinant of an individual's 
tendency to develop an infection by either one or both of 
these organisms. While Candida infections are commonly 
associated with high concentrations of serum glucose, low 
concentrations of this substrate accompanied by a more 
neutral pH may favor the succession of Pseudomonas. 
However, the measurable advantage to the patient 
of a Pseudomonas rather than a Candida infection is highly 
questionable. Since both organisms are the cause of severe 
disease, it is inconceivable that modern medicine would 
risk the purposeful introduction of one pathogen to 
suppress another. 
This report should reaffirm our respect for 
opportunistic infections. Evidence has been presented 
here that suggests that these infections can occur in 
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succession, Candida followed by Pseudomonas, each of which 
is a test of the patient's immunological competence and 
medicine's therapeutic capability. 
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